Baidu
map

Ann Rheum Dis:COVID-19大流行对风湿病患者病程的影响

2020-09-24 xiangting MedSci原创

按照患者报告的结局进行评估,治疗的短暂减少对axSpA、RA和PsA患者的病程没有明显影响。

疫情流行期间,由于采取了一系列的病毒隔离管控措施,慢性病患者的就医、配药等存在困难。这项研究探讨了新冠肺炎流行期间,中轴型脊柱关节炎(axSpA)、类风湿性关节炎(RA)或银屑病关节炎(PsA)患者治疗的短暂减少是否与疾病恶化相关。

研究纳入瑞士临床质量管理队列的666名axSpA、RA和PsA患者,比较了2020年1月至2020年6月共三个阶段的患者报告疾病活动性,(COVID-19流行前、流行期间和流行后)。

结果发现,咨询数量下降了52%,而远程评估数量则增加了129%。大流行期间药物不依从的患者比例略有增加,在axSpA患者中这种差异达到了统计学显著性(流行前为13.2%,流行期间为19.9%,p=0.003)。疾病急性发作的患者比例保持稳定(<15%)。axSpA、RA和PsA患者的巴斯强直性脊柱炎疾病活动度指数、类风湿性关节炎疾病活动指数-5和患者总体评估的平均值没有升高。

由此可见,按照患者报告的结局进行评估,治疗的短暂减少对axSpA、RA和PsA患者的病程没有明显影响。

原始出处:

Adrian Ciurea. Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis. September 2020.

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2013483, encodeId=5419201348337, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Jun 27 20:23:20 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888161, encodeId=ca6d888161c1, content=按照患者报告的结局进行评估,治疗的短暂减少对axSpA、RA和PsA患者的病程没有明显影响。<a href='/topic/show?id=ece710083962' target=_blank style='color:#2F92EE;'>#风湿科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100839, encryptionId=ece710083962, topicName=风湿科)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Sep 25 08:20:25 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888143, encodeId=13f188814367, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=914c5128619, createdName=1464f43bm88暂无昵称, createdTime=Fri Sep 25 06:31:22 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888070, encodeId=6b418880e03f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Thu Sep 24 21:17:53 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888060, encodeId=5b8688806049, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Thu Sep 24 20:36:10 CST 2020, time=2020-09-24, status=1, ipAttribution=)]
    2021-06-27 cmj8wellington
  2. [GetPortalCommentsPageByObjectIdResponse(id=2013483, encodeId=5419201348337, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Jun 27 20:23:20 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888161, encodeId=ca6d888161c1, content=按照患者报告的结局进行评估,治疗的短暂减少对axSpA、RA和PsA患者的病程没有明显影响。<a href='/topic/show?id=ece710083962' target=_blank style='color:#2F92EE;'>#风湿科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100839, encryptionId=ece710083962, topicName=风湿科)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Sep 25 08:20:25 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888143, encodeId=13f188814367, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=914c5128619, createdName=1464f43bm88暂无昵称, createdTime=Fri Sep 25 06:31:22 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888070, encodeId=6b418880e03f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Thu Sep 24 21:17:53 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888060, encodeId=5b8688806049, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Thu Sep 24 20:36:10 CST 2020, time=2020-09-24, status=1, ipAttribution=)]
    2020-09-25 lovetcm

    按照患者报告的结局进行评估,治疗的短暂减少对axSpA、RA和PsA患者的病程没有明显影响。#风湿科#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2013483, encodeId=5419201348337, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Jun 27 20:23:20 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888161, encodeId=ca6d888161c1, content=按照患者报告的结局进行评估,治疗的短暂减少对axSpA、RA和PsA患者的病程没有明显影响。<a href='/topic/show?id=ece710083962' target=_blank style='color:#2F92EE;'>#风湿科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100839, encryptionId=ece710083962, topicName=风湿科)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Sep 25 08:20:25 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888143, encodeId=13f188814367, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=914c5128619, createdName=1464f43bm88暂无昵称, createdTime=Fri Sep 25 06:31:22 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888070, encodeId=6b418880e03f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Thu Sep 24 21:17:53 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888060, encodeId=5b8688806049, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Thu Sep 24 20:36:10 CST 2020, time=2020-09-24, status=1, ipAttribution=)]
    2020-09-25 1464f43bm88暂无昵称

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2013483, encodeId=5419201348337, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Jun 27 20:23:20 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888161, encodeId=ca6d888161c1, content=按照患者报告的结局进行评估,治疗的短暂减少对axSpA、RA和PsA患者的病程没有明显影响。<a href='/topic/show?id=ece710083962' target=_blank style='color:#2F92EE;'>#风湿科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100839, encryptionId=ece710083962, topicName=风湿科)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Sep 25 08:20:25 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888143, encodeId=13f188814367, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=914c5128619, createdName=1464f43bm88暂无昵称, createdTime=Fri Sep 25 06:31:22 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888070, encodeId=6b418880e03f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Thu Sep 24 21:17:53 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888060, encodeId=5b8688806049, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Thu Sep 24 20:36:10 CST 2020, time=2020-09-24, status=1, ipAttribution=)]
    2020-09-24 飞翔的乌龟

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2013483, encodeId=5419201348337, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Jun 27 20:23:20 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888161, encodeId=ca6d888161c1, content=按照患者报告的结局进行评估,治疗的短暂减少对axSpA、RA和PsA患者的病程没有明显影响。<a href='/topic/show?id=ece710083962' target=_blank style='color:#2F92EE;'>#风湿科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100839, encryptionId=ece710083962, topicName=风湿科)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Sep 25 08:20:25 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888143, encodeId=13f188814367, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=914c5128619, createdName=1464f43bm88暂无昵称, createdTime=Fri Sep 25 06:31:22 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888070, encodeId=6b418880e03f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Thu Sep 24 21:17:53 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888060, encodeId=5b8688806049, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Thu Sep 24 20:36:10 CST 2020, time=2020-09-24, status=1, ipAttribution=)]
    2020-09-24 医鸣惊人

    学习

    0

相关资讯

J Rheumatol:腹型肥胖与普通肥胖女性患类风湿性关节炎风险的比较

腹型肥胖与年轻和中年女性的RA风险升高相关,特别是血清学阳性RA。

Sci Rep:来氟米特单药治疗类风湿性关节炎与联合疗法的比较

这些结果表明低剂量LEF单药治疗并不劣于联合治疗。

NEJM:PRIME细胞与类风湿性关节炎发作

对类风湿性关节炎患者进行基因组分析显示,耀斑爆发前,血液中存在的PRIME细胞通过B细胞激活后,从血液中迁移到滑膜,导致患者症状加重

Ann Rheum Dis:"程序化 "英夫利昔单抗(IFX)治疗策略治疗类风湿性关节炎的效果如何?

本研究旨在确定 "程序化 "英夫利昔单抗(IFX)治疗策略(对于该策略,根据基线血清肿瘤坏死因子α(TNF-α)调整IFX的剂量)是否有利于在54周后诱导临床缓解,并持续停用I

Adv Mater:深圳先进院等在类风湿性关节炎诊疗的光声分子成像研究中获进展

近日,中国科学院深圳先进技术研究院医工所生物医学光学与分子影像研究室副研究员刘成波团队、转化医学中心研究员张鹏团队与南开大学教授丁丹团队合作,在类风湿性关节炎诊疗的光声分子成像研究方面取得突破。

Ann Rheum Dis:巴瑞克替尼治疗活动性类风湿性关节炎的感染率

接受巴瑞克替尼治疗的类风湿性关节炎患者需要紧急治疗的感染发病率升高,其中包括带状疱疹。

Baidu
map
Baidu
map
Baidu
map